Thus, the fact that multiple cytokines synergize in modulating C3 expression would explain why TGF-β, IL-33, and IL-1β activity blockade did not fully inhibit the expression of C3 in MCs treated with melanoma cell culture supernatants. Here, IL33 is linked to melanoma.